REGAL clinical trial: Principal Investigator

Activity: Other activity typesOther

Description

REGAL: Capturing trastuzumab REsistance in Gastroesophageal Adenocarcinoma by Liquid biopsy
Period18 May 202121 Feb 2025
Held atUniversity of Dundee, United Kingdom
Degree of RecognitionInternational